Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Outcomes of Gamma Knife Radiosurgery for Metastatic Brain Tumors from Gynecologic Cancer : Prognostic Factors in Local Treatment Failure and Survival

  • Shin, Hong Kyung (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jeong Hoon (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Do Heui (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Cho, Young Hyun (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kwon, Do Hoon (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Roh, Sung Woo (Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2015.12.02
  • Accepted : 2016.04.07
  • Published : 2016.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Brain metastases in gynecologic cancer (ovarian, endometrial, and cervical cancer) patients are rare, and the efficacy of Gamma Knife Radiosurgery (GKRS) to treat these had not been evaluated. We assessed the efficacy of GKRS and prognostic factors for tumor control and survival in brain metastasis from gynecologic cancers. Methods : This retrospective study was approved by the institutional review board. From May 1995 to October 2012, 26 women (mean age 51.3 years, range 27-70 years) with metastatic brain tumors from gynecologic cancer were treated with GKRS. We reviewed their outcomes, radiological responses, and clinical status. Results : In total 24 patients (59 lesions) were available for follow-up imaging. The median follow-up time was 9 months. The mean treated tumor volume at the time of GKRS was $8185mm^3$ (range $10-19500mm^3$), and the median dose delivered to the tumor margin was 25 Gy (range, 10-30 Gy). A local tumor control rate was 89.8% (53 of 59 tumors). The median overall survival was 9.5 months after GKRS (range, 1-102 months). Age-associated multivariate analysis indicated that the Karnofsky performance status (KPS), the recursive partitioning analysis (RPA) classification, and the number of treated lesions were significant prognostic factors for overall survival (HR=0.162, p=0.008, HR=0.107, p=0.038, and HR=2.897, p=0.045, respectively). Conclusion : GKRS is safe and effective for the management of brain metastasis from gynecologic cancers. The clinical status of the patient is important in determining the overall survival time.

Keywords

References

  1. Bindal RK, Sawaya R, Leavens ME, Lee JJ : Surgical treatment of multiple brain metastases. J Neurosurg 79 : 210-216, 1993 https://doi.org/10.3171/jns.1993.79.2.0210
  2. Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, et al. : Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer : promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. J Clin Oncol 23 : 3480-3487, 2005 https://doi.org/10.1200/JCO.2005.12.120
  3. Brown JV 3rd, Goldstein BH, Duma CM, Rettenmaier MA, Micha JP : Gamma-knife radiosurgery for the treatment of ovarian cancer metastatic to the brain. Gynecol Oncol 97 : 858-861, 2005 https://doi.org/10.1016/j.ygyno.2005.02.019
  4. Chen PG, Lee SY, Barnett GH, Vogelbaum MA, Saxton JP, Fleming PA, et al. : Use of the Radiation Therapy Oncology Group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma. Cancer 104 : 2174-2180, 2005 https://doi.org/10.1002/cncr.21472
  5. Chi A, Komaki R : Treatment of brain metastasis from lung cancer. Cancers (Basel) 2 : 2100-2137, 2010 https://doi.org/10.3390/cancers2042100
  6. Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA : Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer : a retrospective analysis and literature review. Gynecol Oncol 107 : 79-85, 2007 https://doi.org/10.1016/j.ygyno.2007.05.027
  7. Cohen ZR, Suki D, Weinberg JS, Marmor E, Lang FF, Gershenson DM, et al. : Brain metastases in patients with ovarian carcinoma : prognostic factors and outcome. J Neurooncol 66 : 313-325, 2004 https://doi.org/10.1023/B:NEON.0000014516.04943.38
  8. Cormio G, Lissoni A, Losa G, Zanetta G, Pellegrino A, Mangioni C : Brain metastases from endometrial carcinoma. Gynecol Oncol 61 : 40-43, 1996 https://doi.org/10.1006/gyno.1996.0093
  9. Corn BW, Mehta MP, Buatti JM, Wolfson AH, Greven KM, Kim RY, et al. : Stereotactic irradiation : potential new treatment method for brain metastases resulting from ovarian cancer. Am J Clin Oncol 22 : 143-146, 1999 https://doi.org/10.1097/00000421-199904000-00007
  10. Eccles SA, Welch DR : Metastasis : recent discoveries and novel treatment strategies. Lancet 369 : 1742-1757, 2007 https://doi.org/10.1016/S0140-6736(07)60781-8
  11. Flickinger JC : Radiotherapy and radiosurgical management of brain metastases. Curr Oncol Rep 3 : 484-489, 2001 https://doi.org/10.1007/s11912-001-0069-5
  12. Geisler JP, Geisler HE : Brain metastases in epithelial ovarian carcinoma. Gynecol Oncol 57 : 246-249, 1995 https://doi.org/10.1006/gyno.1995.1134
  13. Kim TJ, Song S, Kim CK, Kim WY, Choi CH, Lee JH, et al. : Prognostic factors associated with brain metastases from epithelial ovarian carcinoma. Int J Gynecol Cancer 17 : 1252-1257, 2007 https://doi.org/10.1111/j.1525-1438.2007.00941.x
  14. Kim YZ, Kwon JH, Lim S : A clinical analysis of brain metastasis in gynecologic cancer : a retrospective multi-institute analysis. J Korean Med Sci 30 : 66-73, 2015 https://doi.org/10.3346/jkms.2015.30.1.66
  15. Kolomainen DF, Larkin JM, Badran M, A'Hern RP, King DM, Fisher C, et al. : Epithelial ovarian cancer metastasizing to the brain : a late manifestation of the disease with an increasing incidence. J Clin Oncol 20 : 982-986, 2002 https://doi.org/10.1200/JCO.2002.20.4.982
  16. Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP : Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol 108 : 505-509, 2008 https://doi.org/10.1016/j.ygyno.2007.11.027
  17. Mayer RJ, Berkowitz RS, Griffiths CT : Central nervous system involvement by ovarian carcinoma : a complication of prolonged survivial with metastatic disease. Cancer 41 : 776-783, 1978 https://doi.org/10.1002/1097-0142(197802)41:2<776::AID-CNCR2820410253>3.0.CO;2-E
  18. McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, et al. : Ovarian cancer metastatic to the brain : what is the optimal management? J Surg Oncol 78 : 194-200; discussion 200-201, 2001 https://doi.org/10.1002/jso.1149
  19. Menendez JY, Bauer DF, Shannon CN, Fiveash J, Markert JM : Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system. J Neurooncol 109 : 513-519, 2012 https://doi.org/10.1007/s11060-012-0916-2
  20. Momose T, Nariai T, Kawabe T, Inaji M, Tanaka Y, Watanabe S, et al. : Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases. Clin Nucl Med 39 : 939-943, 2014 https://doi.org/10.1097/RLU.0000000000000561
  21. Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD : Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer 113 : 2610-2614, 2008 https://doi.org/10.1002/cncr.23868
  22. Muacevic A, Kreth FW, Horstmann GA, Schmid-Elsaesser R, Wowra B, Steiger HJ, et al. : Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 91 : 35-43, 1999 https://doi.org/10.3171/jns.1999.91.1.0035
  23. Nasu K, Satoh T, Nishio S, Nagai Y, Ito K, Otsuki T, et al. : Clinicopathologic features of brain metastases from gynecologic malignancies : a retrospective study of 139 cases (KCOG-G1001s trial). Gynecol Oncol 128 : 198-203, 2013 https://doi.org/10.1016/j.ygyno.2012.11.001
  24. Navarro-Martín A, Maitz A, Manders M, Ducharme E, Chen P, Grills I : Gamma Knife radiosurgery as a primary treatment option for solitary brain metastases from ovarian carcinoma. Clin Transl Oncol 11 : 326-328, 2009 https://doi.org/10.1007/s12094-009-0362-6
  25. Ogawa K, Yoshii Y, Aoki Y, Nagai Y, Tsuchida Y, Toita T, et al. : Treatment and prognosis of brain metastases from gynecological cancers. Neurol Med Chir (Tokyo) 48 : 57-62; discussion 62-63, 2008 https://doi.org/10.2176/nmc.48.57
  26. Ogino A, Hirai T, Fukushima T, Serizawa T, Watanabe T, Yoshino A, et al. : Gamma knife surgery for brain metastases from ovarian cancer. Acta Neurochir (Wien) 154 : 1669-1677, 2012 https://doi.org/10.1007/s00701-012-1376-3
  27. Patchell RA : Brain metastases. Neurol Clin 9 : 817-824, 1991
  28. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. : A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 : 494-500, 1990 https://doi.org/10.1056/NEJM199002223220802
  29. Piura E, Piura B : Brain metastases from cervical carcinoma : overview of pertinent literature. Eur J Gynaecol Oncol 33 : 567-573, 2012
  30. Piura E, Piura B : Brain metastases from endometrial carcinoma. ISRN Oncol 2012 : 581749, 2012
  31. Piura E, Piura B : Brain metastases from ovarian carcinoma. ISRN Oncol 2011 : 527453, 2011
  32. Ratner ES, Toy E, O'Malley DM, McAlpine J, Rutherford TJ, Azodi M, et al. : Brain metastases in epithelial ovarian and primary peritoneal carcinoma. Int J Gynecol Cancer 19 : 856-859, 2009 https://doi.org/10.1111/IGC.0b013e3181a83301
  33. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A : Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94 : 2698-2705, 2002 https://doi.org/10.1002/cncr.10541
  34. Shepard MJ, Fezeu F, Lee CC, Sheehan JP : Gamma knife radiosurgery for the treatment of gynecologic malignancies metastasizing to the brain : clinical article. J Neurooncol 120 : 515-522, 2014 https://doi.org/10.1007/s11060-014-1577-0
  35. Simonova G, Liscak R, Novotny J Jr, Novotny J : Solitary brain metastases treated with the Leksell gamma knife : prognostic factors for patients. Radiother Oncol 57 : 207-213, 2000 https://doi.org/10.1016/S0167-8140(00)00267-X
  36. Sohn MJ, Kwon Y, Kim JH, Jeon SR, Lee DJ, Kim CJ, et al. : Clinical analysis of gamma knife radiosurgery for brain metastases. J Korean Neurosurg Soc 28 : 649-657, 1999
  37. Tendulkar RD, Liu SW, Barnett GH, Vogelbaum MA, Toms SA, Jin T, et al. : RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 66 : 810-817, 2006 https://doi.org/10.1016/j.ijrobp.2006.06.003
  38. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. : Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49 : 694-699, 2008 https://doi.org/10.2967/jnumed.107.048082
  39. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, et al. : Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery : is a differential diagnosis possible? J Neurosurg 98 : 1056-1064, 2003 https://doi.org/10.3171/jns.2003.98.5.1056
  40. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH : Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104 : 907-912, 2006 https://doi.org/10.3171/jns.2006.104.6.907

Cited by

  1. Role of Gamma Knife® Radiosurgery for the Treatment of Brain Metastases from Gynecological Cancers vol.8, pp.12, 2016, https://doi.org/10.7759/cureus.947
  2. Efficacy of gamma knife radiosurgery in brain metastases of primary gynecological tumors vol.142, pp.2, 2016, https://doi.org/10.1007/s11060-019-03094-2
  3. Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis vol.19, pp.1, 2016, https://doi.org/10.1186/s12885-019-6382-x
  4. Brain Metastases from Uterine Cervical and Endometrial Cancer vol.13, pp.3, 2016, https://doi.org/10.3390/cancers13030519